Recent publications of Keiji Nakamura, Ph.D., Pharma Forum Institute
	Prasugrel tops predicted Japan blockbusters
	SCRIP  No.3347 page 20-21, March 25 2008
	Current new drug development in the Japanese pharmaceutical industry
	Pharma Japan No.2077 pp12-18 February 11 2008
	Anticancer drugs and candidates under development of pharmaceutical companies in the world
	New Drug Candidates Vol 18 No 7 pp1-452 July 2007
	Prasugrel heads up potential Japanese-origin blockbusters
	SCRIP  No.3238 page 14 March 2nd 2007
	Breakthrough candidates of Japanese pharmaceutical companies
	Pharma Japan No.2028 pp10-16 February 12 2007
	New Drug Candidates 17 pp319-379 January 2007
	News from the Japanese Pharma Licensing Association (JPLA)
	Business Development & Licensing Journal, UK pp4-5, Autumn 2006
	Blockbuster sales of international majors in 2005: rankings of companies and therapeutic areas
	Pharma Japan No.2004, pp 13-17 August 14 & 21 　　　　　　New Drug Candidates 17 No.3 pp175-195 April 2006
	Prasugrel set to top Japanese blockbusters
	SCRIP No.3140 page No. p24 March 14 2006
	Blockbuster candidates from Japanese pharmaceutical companies in 2006
	Pharma Japan extra issue No.1988 April 17 2006 　　　　　　New Drug Candidates 16 No.11 pp315-323 January 2006
	Vascular calcification, ultimate consequence of vascular atherosclerosis
	New Drug Candidates 16 No.183-191 December 2005 　　　　　　Pharma Japan No.1976 pp12-15, ibid No.1977 pp12-14 2006
	A cluster of diseases, “metabolic syndrome”, reflecting on aging society
	New Drug Candidates 16 No.7 pp196-202 September 2005, and 　　　　　　Pharma Japan No.1965 pp15-18 October 31 2005, 　　　　　ibid No.1966 pp12-13 Nov 7 2005
	Type 2 diabetes mellitus: expanding therapeutic strategy
	New Drug Candidates 16 No.4 pp203-214 May 2005, and 　　　　　　Pharma Japan No.1947 pp17-20 June 20 2005; 　　　　　　ibid No.1948 pp16-17 June 27 2005; 　　　　　　ibid No.1949 pp13-15 July 4 2005
	Blockbuster candidates from Japanese pharmaceutical companies in 2005
	New Drug Candidates 15 No.11 pp313-316 January 2005.
	Emerging new therapeutics against hypercholesterolemia and atherosclerosis: Lipitor, a golden standard ?
	New Drug Candidates 15 No.10 pp191-195 December 2004.